BioVaxys Announces Appointment of Corporate Advisor News provided by Share this article VANCOUVER, BC, Feb. 12, 2021 /PRNewswire/ -- BioVaxys Technology Corp. ( CSE: BIOV) (FRA: 5LB) ("BioVaxys" or "the Company") is pleased to announce that is has appointed Shmuel Farhi as Corporate Advisor to the Company. Mr. Farhi, founder and President of Farhi Holding Corporation, a company that owns more than four million square feet of properties across Ontario, Canada, is a prolific investor in the Canadian, American, and Israeli biotech industry. James Passin, CEO of BioVaxys, stated, "BioVaxys is delighted to onboard the legendary billionaire developer, philanthropist, and biotech financier, Shmuel Farhi, as Corporate Advisor. We look forward to leveraging the deep business expertise of Shmuel, who is now one of BioVaxys's largest shareholders, as we continue to advance the clinical and commercial development of BVX-0320, BVX-0918A, and COVID-T™."